Market Overview:
The global non-LVP parenterals products market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for non-LVP parenterals products due to their superior properties, such as high purity and low endotoxin levels. In addition, the growing prevalence of chronic diseases is also contributing to the growth of this market. On the basis of type, ampules are expected to account for a major share of the global non-LVP parenterals products market in 2018. This can be attributed to their small size and ease of use.
Product Definition:
A non-LVP parenteral is a product that does not contain low-viscosity polyethylene glycol (PEG). Non-LVP parenterals are important for delivering medications and other treatments into the body. They are often used to treat serious medical conditions because they can deliver large doses of medication quickly and effectively.
Ampules:
Ampules are small glass or plastic vials containing a precise amount of drug. They are used in various parenteral products such as intravenous solutions, injections, and syrup. Ampules reduce the risk of contamination because they have a smaller surface area that is exposed to the external environment and can be closed without any possibility of spillage.
Vials:
Vials and it's usage in Non-LVP parenteral products market is expected to witness significant growth over the forecast period. Vials are glass or plastic bottles used for storing liquid or semi-solid pharmaceutical formulations. They are available in various shapes and sizes, depending on the product to be stored.
Application Insights:
The local anesthetics segment dominated the global non-LVP parenterals products market in 2017. This is attributed to increasing demand for these products for dental procedures and pain management. Furthermore, favorable reimbursement policies are expected to drive the segment over the forecast period. Vaccines application is anticipated to witness significant growth during the forecast period owing to high demand for immunization against a number of diseases, including chickenpox, typhoid fever, cholera and measles among others.
Other applications include nutritional supplements & vitamins as well as blood glucose testing equipment & supplies.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high awareness among people about immunization programs, and increasing R&D activities for new product development are some of the major factors responsible for North America’s dominance. Moreover, an increase in the number of surgical procedures is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India and China. In addition, a rise in per capita income levels will boost consumer spending on health products; which will further fuel demand during the projected time frame.
Growth Factors:
- Increasing demand for non-LVP parenterals products due to the rise in incidence of chronic diseases and growing geriatric population.
- Technological advancements in manufacturing processes of non-LVP parenterals products that offer better quality and safety.
- Rising awareness about the benefits of using non-LVP parenterals products among healthcare professionals and patients alike.
- Growing number of private sector players in the market, offering a wider choice to consumers with respect to price, quality, and features of different brands/products available in the market place .
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-LVP Parenterals Products Market Research Report
By Type
Ampules, Vials, Prefilled Syringes
By Application
Local Anesthetics, Vaccines, Other
By Companies
Allergan, Bayer, GSK, J&J, Pfizer, Teva, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Non-LVP Parenterals Products Market Report Segments:
The global Non-LVP Parenterals Products market is segmented on the basis of:
Types
Ampules, Vials, Prefilled Syringes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Local Anesthetics, Vaccines, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Bayer
- GSK
- J&J
- Pfizer
- Teva
- Novartis
Highlights of The Non-LVP Parenterals Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ampules
- Vials
- Prefilled Syringes
- By Application:
- Local Anesthetics
- Vaccines
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-LVP Parenterals Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-LVP Parenterals Products are medications that are not injected into the body. They include intravenous fluids, medications for treating heart failure, and other treatments.
Some of the key players operating in the non-lvp parenterals products market are Allergan, Bayer, GSK, J&J, Pfizer, Teva, Novartis.
The non-lvp parenterals products market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-LVP Parenterals Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-LVP Parenterals Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-LVP Parenterals Products Market - Supply Chain
4.5. Global Non-LVP Parenterals Products Market Forecast
4.5.1. Non-LVP Parenterals Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-LVP Parenterals Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-LVP Parenterals Products Market Absolute $ Opportunity
5. Global Non-LVP Parenterals Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-LVP Parenterals Products Market Size and Volume Forecast by Type
5.3.1. Ampules
5.3.2. Vials
5.3.3. Prefilled Syringes
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-LVP Parenterals Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-LVP Parenterals Products Market Size and Volume Forecast by Application
6.3.1. Local Anesthetics
6.3.2. Vaccines
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-LVP Parenterals Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-LVP Parenterals Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-LVP Parenterals Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-LVP Parenterals Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-LVP Parenterals Products Demand Share Forecast, 2019-2026
9. North America Non-LVP Parenterals Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-LVP Parenterals Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-LVP Parenterals Products Market Size and Volume Forecast by Application
9.4.1. Local Anesthetics
9.4.2. Vaccines
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-LVP Parenterals Products Market Size and Volume Forecast by Type
9.7.1. Ampules
9.7.2. Vials
9.7.3. Prefilled Syringes
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-LVP Parenterals Products Demand Share Forecast, 2019-2026
10. Latin America Non-LVP Parenterals Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-LVP Parenterals Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-LVP Parenterals Products Market Size and Volume Forecast by Application
10.4.1. Local Anesthetics
10.4.2. Vaccines
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-LVP Parenterals Products Market Size and Volume Forecast by Type
10.7.1. Ampules
10.7.2. Vials
10.7.3. Prefilled Syringes
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-LVP Parenterals Products Demand Share Forecast, 2019-2026
11. Europe Non-LVP Parenterals Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-LVP Parenterals Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-LVP Parenterals Products Market Size and Volume Forecast by Application
11.4.1. Local Anesthetics
11.4.2. Vaccines
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-LVP Parenterals Products Market Size and Volume Forecast by Type
11.7.1. Ampules
11.7.2. Vials
11.7.3. Prefilled Syringes 11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-LVP Parenterals Products Demand Share, 2019-2026
12. Asia Pacific Non-LVP Parenterals Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-LVP Parenterals Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-LVP Parenterals Products Market Size and Volume Forecast by Application
12.4.1. Local Anesthetics
12.4.2. Vaccines
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-LVP Parenterals Products Market Size and Volume Forecast by Type
12.7.1. Ampules
12.7.2. Vials
12.7.3. Prefilled Syringes
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-LVP Parenterals Products Demand Share, 2019-2026
13. Middle East & Africa Non-LVP Parenterals Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-LVP Parenterals Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-LVP Parenterals Products Market Size and Volume Forecast by Application
13.4.1. Local Anesthetics
13.4.2. Vaccines
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-LVP Parenterals Products Market Size and Volume Forecast by Type
13.7.1. Ampules
13.7.2. Vials
13.7.3. Prefilled Syringes
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-LVP Parenterals Products Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-LVP Parenterals Products Market: Market Share Analysis
14.2. Non-LVP Parenterals Products Distributors and Customers
14.3. Non-LVP Parenterals Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GSK
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. J&J
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novartis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
